DelMar Pharmaceuticals, Inc. 4
4 · DelMar Pharmaceuticals, Inc. · Filed Feb 22, 2017
Insider Transaction Report
Form 4
BACHA JEFFREY
CEO and President10% Owner
Transactions
- Award
Options (Right to Buy)
2017-02-17+93,600→ 93,600 totalExercise: $4.95From: 2020-02-17Exp: 2027-02-17→ Common Stock (93,600 underlying)
Footnotes (1)
- [F1]The options vest in equal monthly installments over three years.